Tsuyoshi Kobayashi

39PUBLICATIONS
77CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 21, 2026
Hepatic Carcinoma With Epithelial-Myoepithelial Differentiation and Metachronous Intrahepatic Recurrence Following Curative Resection: A Rare Case Report.

|May 18, 2026
Serum Bile Acids Are Useful Indicators of Intrahepatic Recurrence After Initial Curative Hepatectomy for Hepatocellular Carcinoma.

|Mar 03, 2026
Thrombomodulin Mitigates the Progression of Hepatocellular Carcinoma in Steatotic Liver.

Megumi Yamaguchi, Hirotaka Tashiro, Shintaro Kuroda

|Nov 20, 2025
ASO Visual Abstract: Clinical Significance of Circulating Tumor Cells in the Portal Vein of Patients with Hepatocellular Carcinoma Undergoing Anatomical Liver Resection.

Daisuke Takei, Tsuyoshi Kobayashi, Michinori Hamaoka

|Nov 07, 2025
Preoperative Versus Postoperative Chemotherapy With CAPOX Plus Bevacizumab for Resectable Colorectal Liver Metastases: A Randomized Phase II Trial (HiSCO-01).

Yuji Takakura, Katsunori Shinozaki, Satoshi Ikeda

|Nov 07, 2025
Response to Letter to the Editor Entitled "Clarifying Treatment Compliance and Future Directions in Perioperative Chemotherapy for Resectable Colorectal Liver Metastases".

Katsunori Shinozaki, Tsuyoshi Kobayashi, Yuji Takakura

Pageof 7

Frequent Collaborators

15 joint publications

Masahiro Ohira

13 joint publications

Hiroyuki Tahara

12 joint publications

Hideki Ohdan

8 joint publications

Tomoyuki Abe